By NewsDesk  @infectiousdiseasenews Bavarian Nordic A/S  announced Friday that the Company was recently engaged by Public Health England (PHE) and the Medicines and Health Products Regulatory Agency...

Levels of antibodies in the blood of vaccinated people that are able to recognise and fight the new SARS-CoV-2 Delta variant first discovered in India (B.1.617.2) are on average lower than those against...

By NewsDesk  @infectiousdiseasenews On 27 December 2020, Denmark launched an ambitious vaccination program, where the goal is to offer vaccination against COVID-19 to all Danes aged 16 and over. The...

By NewsDesk  @infectiousdiseasenews According to the Brazil Ministry of Health, the first dose of the Covid-19 vaccine has already reached 29.8% of the eligible population in Brazil. There are 47.6...

By NewsDesk  @infectiousdiseasenews A new study looking across a large body of research finds further evidence for the safety of vaccines that are Food and Drug Administration-approved and routinely...

By NewsDesk  @infectiousdiseasenews A new CDC study adds to the growing body of real-world evidence (outside of a clinical trial setting) showing that COVID-19 mRNA vaccines authorized by the Food and...

In a world-first, Griffith University researchers have developed a new vaccine in pre-clinical studies to treat human babesiosis, a tick-transmitted disease closely related to malaria. Lead researcher Professor...

By NewsDesk  @infectiousdiseasenews A dengue virus vaccine candidate has passed an important milestone, with promising results in animal model testing providing hope to the 390 million people infected...

By NewsDesk  @infectiousdiseasenews Following the initial reports of rare side effects after vaccination with the AstraZeneca vaccine (Vaxevria), a registry study was initiated quickly. The study includes...

More than a quarter of American infants in 2018 had not received common childhood vaccines that protect them from illnesses such as polio, tetanus, measles, mumps and chicken pox, new research from the...